Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01789294Phase 4Unknown
A Phase 4 trial of Salcrozine in Nodular lymphoid hyperplasia (NLH), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01789294.